Parkinson’s disease is a debilitating neurological condition affecting more than 1% of the global population aged 60 and above. The primary medication used to treat this disease is levodopa. The efficacy of the treatment is hugely variable between individuals, depending on the composition of their microbiota. Levodopa is converted into active dopamine, but if the gut microbiota metabolize levodopa before it crosses the blood-brain barrier, medication...
